Your browser doesn't support javascript.
loading
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis.
Laing, Adam G; Lorenc, Anna; Del Molino Del Barrio, Irene; Das, Abhishek; Fish, Matthew; Monin, Leticia; Muñoz-Ruiz, Miguel; McKenzie, Duncan R; Hayday, Thomas S; Francos-Quijorna, Isaac; Kamdar, Shraddha; Joseph, Magdalene; Davies, Daniel; Davis, Richard; Jennings, Aislinn; Zlatareva, Iva; Vantourout, Pierre; Wu, Yin; Sofra, Vasiliki; Cano, Florencia; Greco, Maria; Theodoridis, Efstathios; Freedman, Joshua D; Gee, Sarah; Chan, Julie Nuo En; Ryan, Sarah; Bugallo-Blanco, Eva; Peterson, Pärt; Kisand, Kai; Haljasmägi, Liis; Chadli, Loubna; Moingeon, Philippe; Martinez, Lauren; Merrick, Blair; Bisnauthsing, Karen; Brooks, Kate; Ibrahim, Mohammad A A; Mason, Jeremy; Lopez Gomez, Federico; Babalola, Kola; Abdul-Jawad, Sultan; Cason, John; Mant, Christine; Seow, Jeffrey; Graham, Carl; Doores, Katie J; Di Rosa, Francesca; Edgeworth, Jonathan; Shankar-Hari, Manu; Hayday, Adrian C.
Affiliation
  • Laing AG; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Lorenc A; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Del Molino Del Barrio I; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Das A; UCL Cancer Institute, University College London, London, UK.
  • Fish M; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Monin L; London School of Hygiene & Tropical Medicine, London, UK.
  • Muñoz-Ruiz M; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • McKenzie DR; Department of Intensive Care Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Hayday TS; The Francis Crick Institute, London, UK.
  • Francos-Quijorna I; The Francis Crick Institute, London, UK.
  • Kamdar S; The Francis Crick Institute, London, UK.
  • Joseph M; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Davies D; Regeneration Group, Wolfson Centre for Age-Related Diseases, IoPPN, King's College London, London, UK.
  • Davis R; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Jennings A; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Zlatareva I; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Vantourout P; Department of Plastic and Reconstructive Surgery, Royal Free NHS Foundation Trust, London, UK.
  • Wu Y; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Sofra V; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Cano F; Department of Intensive Care Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Greco M; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Theodoridis E; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Freedman JD; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Gee S; UCL Cancer Institute, University College London, London, UK.
  • Chan JNE; The Francis Crick Institute, London, UK.
  • Ryan S; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Bugallo-Blanco E; The Francis Crick Institute, London, UK.
  • Peterson P; The Francis Crick Institute, London, UK.
  • Kisand K; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Haljasmägi L; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Chadli L; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Moingeon P; Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
  • Martinez L; Department of Inflammation Biology, King's College London, London, UK.
  • Merrick B; Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
  • Bisnauthsing K; Molecular Pathology Research Group, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
  • Brooks K; Molecular Pathology Research Group, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
  • Ibrahim MAA; Molecular Pathology Research Group, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
  • Mason J; Center for Therapeutic Innovation in Immuno-inflammation, Servier, France.
  • Lopez Gomez F; Center for Therapeutic Innovation in Immuno-inflammation, Servier, France.
  • Babalola K; Infectious Diseases Department, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Abdul-Jawad S; Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Cason J; Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Mant C; Infectious Diseases Department, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Seow J; Immunological Medicine, Kings College Hospital NHS Foundation Trust, London, UK.
  • Graham C; The European Bioinformatics Institute (EMBL-EBI) Wellcome Genome Campus, Hinxton, UK.
  • Doores KJ; The European Bioinformatics Institute (EMBL-EBI) Wellcome Genome Campus, Hinxton, UK.
  • Di Rosa F; The European Bioinformatics Institute (EMBL-EBI) Wellcome Genome Campus, Hinxton, UK.
  • Edgeworth J; Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
  • Shankar-Hari M; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Hayday AC; Infectious Diseases Biobank, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
Nat Med ; 26(12): 1951, 2020 Dec.
Article in En | MEDLINE | ID: mdl-33247289
A Correction to this paper has been published: https://doi.org/10.1038/s41591-020-01186-5.
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2020 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2020 Document type: Article Country of publication: Estados Unidos